학술논문
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Document Type
Article
Author
Source
In: Cancers . (Cancers, March 2024, 16(5))
Subject
Language
English
ISSN
20726694